Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
NCT ID: NCT00890149
Last Updated: 2023-05-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
74 participants
INTERVENTIONAL
2015-09-30
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief Youth Substance Use Intervention for Primary Care
NCT00292240
Brief Intervention for Heavy Drinkers
NCT00728767
Evaluating Telehealth Delivery of Brief Alcohol Screening and Intervention for College Students
NCT06774300
Reducing Hazardous Alcohol Use in Social Networks Using Targeted Intervention: 21 Rising
NCT04147520
The Canadian Underage Substance Use Prevention Trial
NCT04198974
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ondansetron
Ondansetron + BASICS Plus
Ondansetron
Ondansetron (4ug/kg bid),
BASICS Plus
Brief Alcohol Screening and Intervention for College Students. Brief behavioral intervention to reduce drinking.
Placebo
Placebo + BASICS Plus
Placebo
Placebo bid
BASICS Plus
Brief Alcohol Screening and Intervention for College Students. Brief behavioral intervention to reduce drinking.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ondansetron
Ondansetron (4ug/kg bid),
Placebo
Placebo bid
BASICS Plus
Brief Alcohol Screening and Intervention for College Students. Brief behavioral intervention to reduce drinking.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 18 through 25;also, patients must weigh ≥40 kg and ≤140 kg.
* Good physical health as determined by a complete physical examination, an EKG within normal limits, and laboratory screening tests within acceptable parameters.
* At least an average of one episode of binge or heavy drinking per week in the past month prior to enrollment. For men and women, that is ≥5 and ≥4 drinks/drinking day, respectively.They also need to report at least one day of heavy drinking within the 7 days prior to randomization.
* The pregnancy test for females at intake must be negative. Additionally, women of childbearing potential must be using an acceptable form of contraception.
* Literate in English and able to read, understand, and complete the rating scales and questionnaires accurately, follow instructions, and make use of the behavioral treatments.
* Answer an advertisement in the newspaper/radio/television, and express a wish to stop heavy drinking.
* Willingness to participate in behavioral treatments to stop heavy drinking
Exclusion Criteria
18 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
University of Maryland, Baltimore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bankole Johnson, DSc,MD,PhD
Role: PRINCIPAL_INVESTIGATOR
University of Maryland, Baltimore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Neurobehavioral Center
Columbia, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00063000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.